Table 3.
C-statistics of SHR3 for predicting MACEs in STEMI
| Models | C-statistics (95% CI) | ΔC-statistics (95% CI) | p-value |
|---|---|---|---|
| Total population | |||
| Original model* | 0.765 (0.750–0.781) | – | |
| Original model + SHR3 | 0.773 (0.758–0.788) | 0.008 (0.000–0.013) | 0.015 |
| DM | |||
| Original model* | 0.755 (0.724–0.785) | – | |
| Original model + SHR3 | 0.764 (0.734–0.794) | 0.010 (0.003–0.017) | 0.008 |
| Non-DM | |||
| Original model* | 0.770 (0.752–0.788) | – | |
| Original model + SHR3 | 0.777 (0.760–0.794) | 0.007 (0.002–0.013) | 0.007 |
CI confidence interval, DM diabetes mellitus, Non-DM non-diabetes mellitus, SHR stress hyperglycemia ratio
*Original model included age, SBP, HR, Killip classification, diabetes, hypertension, angina, weight, anterior STE or LBBB, time to treatment > 4 h (TIMI risk score)